Literature DB >> 25742898

Human T lymphotropic virus type-1-associated myelopathy manifesting shortly after living-donor renal transplantation.

Yuito Nagamine1, Takeshi Hayashi, Yuji Kato, Yohsuke Horiuchi, Norio Tanahashi.   

Abstract

A 38-year-old woman experienced numbness in both lower extremities and spastic paralysis a few months after undergoing living-donor renal transplantation. The patient was negative for human T lymphotropic virus type-1 (HTLV-1) antibodies prior to the procedure; however, she was diagnosed with HTLV-1-associated myelopathy (HAM) based on positive serum and cerebrospinal fluid antibody titers after the surgery. Because the donor was also positive for HTLV-1 antibodies, the infection likely originated from the transplanted kidney. Clinical and imaging improvements were noted following the administration of interferon-α. HAM has been reported to occur after living-donor renal transplantation; however, there are no previous reports of onset within such a short period.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25742898     DOI: 10.2169/internalmedicine.54.2950

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  HTLV-1-associated myelopathy in a solid organ transplant recipient.

Authors:  Maria Jose Montesdeoca Andrade; Edgar Patricio Correa Diaz; Maria Eugenia Buestán
Journal:  BMJ Case Rep       Date:  2016-06-06

2.  Two Cases of Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis Caused by Living-Donor Renal Transplantation.

Authors:  Yasutaka Tajima; Mariko Matsumura; Hiroaki Yaguchi; Yasunori Mito
Journal:  Case Rep Neurol Med       Date:  2016-09-29

3.  Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients.

Authors:  Lucy B M Cook; Anat Melamed; Maria Antonietta Demontis; Daniel J Laydon; James M Fox; Jennifer H C Tosswill; Declan de Freitas; Ashley D Price; James F Medcalf; Fabiola Martin; James M Neuberger; Charles R M Bangham; Graham P Taylor
Journal:  Retrovirology       Date:  2016-01-08       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.